Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

The Cognitive Profile of Persons with Obsessive Compulsive Disorder with and without Autism Spectrum Disorder.

Ekman E, Hiltunen AJ.

Clin Pract Epidemiol Ment Health. 2018 Nov 30;14:304-311. doi: 10.2174/1745017901814010304. eCollection 2018.

2.

Affective Changes During Cognitive Behavioural Therapy-As Measured by PANAS.

Saxon L, Henriksson S, Kvarnström A, Hiltunen AJ.

Clin Pract Epidemiol Ment Health. 2017 Aug 25;13:115-124. doi: 10.2174/1745017901713010115. eCollection 2017.

3.

Cognitive behavioural therapy and mindfulness for stress and burnout: a waiting list controlled pilot study comparing treatments for parents of children with chronic conditions.

Anclair M, Lappalainen R, Muotka J, Hiltunen AJ.

Scand J Caring Sci. 2018 Mar;32(1):389-396. doi: 10.1111/scs.12473. Epub 2017 Aug 29.

PMID:
28851063
4.

Cognitive Behavioural Therapy and Mindfulness for Health-Related Quality of Life: Comparing Treatments for Parents of Children with Chronic Conditions - A Pilot Feasibility Study.

Anclair M, Hjärthag F, Hiltunen AJ.

Clin Pract Epidemiol Ment Health. 2017 Jan 23;13:1-9. doi: 10.2174/1745017901713010001. eCollection 2017.

5.

Effectiveness of cognitive behavioral therapy on health-related quality of life: An evaluation of therapies provided by trainee therapists.

Henriksson S, Anclair M, Hiltunen AJ.

Scand J Psychol. 2016 Jun;57(3):215-22. doi: 10.1111/sjop.12291.

PMID:
27119256
6.

Syntheses, Charge Separation, and Inverted Bulk Heterojunction Solar Cell Application of Phenothiazine-Fullerene Dyads.

Blanco GD, Hiltunen AJ, Lim GN, KC CB, Kaunisto KM, Vuorinen TK, Nesterov VN, Lemmetyinen HJ, D'Souza F.

ACS Appl Mater Interfaces. 2016 Apr 6;8(13):8481-90. doi: 10.1021/acsami.6b00561. Epub 2016 Mar 28.

PMID:
26990247
7.
8.
9.

Should mood during intravenous alcohol administration be studied as a bi- or unipolar phenomenon? a pilot study.

Saxon L, Skagerberg S, Borg S, Hiltunen AJ.

Alcohol. 2010 Aug;44(5):393-400. doi: 10.1016/j.alcohol.2010.05.007. Epub 2010 Jun 18.

PMID:
20804941
10.

The first 38 methadone maintenance treatment patients in Stockholm: 15-year follow-up with a main focus on detoxification from methadone.

Hiltunen AJ, Eklund C, Borg S.

Nord J Psychiatry. 2011 Apr;65(2):106-11. doi: 10.3109/08039488.2010.503904. Epub 2010 Jul 22.

PMID:
20662685
11.

Benzodiazepine tapering: a prospective study.

Vikander B, Koechling UM, Borg S, Tönne U, Hiltunen AJ.

Nord J Psychiatry. 2010 Aug;64(4):273-82. doi: 10.3109/08039481003624173.

PMID:
20629611
12.

Reduction of aggression during benzodiazepine withdrawal: effects of flumazenil.

Saxon L, Borg S, Hiltunen AJ.

Pharmacol Biochem Behav. 2010 Aug;96(2):148-51. doi: 10.1016/j.pbb.2010.04.023. Epub 2010 May 6.

PMID:
20451546
13.

Withdrawal from methadone maintenance treatment. Reasons for not trying to quit methadone.

Hiltunen AJ, Eklund C.

Eur Addict Res. 2002 Jan;8(1):38-44.

PMID:
11818692
14.

Gender-related differences in response to placebo in benzodiazepine withdrawal: a single-blind pilot study.

Saxon L, Hiltunen AJ, Hjemdahl P, Borg S.

Psychopharmacology (Berl). 2001 Jan 1;153(2):231-7.

PMID:
11205424
15.
16.

Prediction of single episodes of drinking during the treatment of alcohol-dependent patients.

Högström Brandt AM, Thorburn D, Hiltunen AJ, Borg S.

Alcohol. 1999 May;18(1):35-42.

PMID:
10386663
17.

Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment.

Hiltunen AJ, Beck O, Hjemdahl P, Liljeberg P, Almström U, Brodin K, von Wachenfeldt J, Borg S.

Psychopharmacology (Berl). 1999 Apr;143(4):385-93.

PMID:
10367556
20.

Effects of flumazenil in the treatment of benzodiazepine withdrawal--a double-blind pilot study.

Saxon L, Hjemdahl P, Hiltunen AJ, Borg S.

Psychopharmacology (Berl). 1997 May;131(2):153-60.

PMID:
9201803
21.

Abstinence fear in methadone maintenance withdrawal: a possible obstacle for getting off methadone.

Eklund C, Hiltunen AJ, Melin L, Borg S.

Subst Use Misuse. 1997 May;32(6):779-92.

PMID:
9178443
23.
24.

Sub-populations of alcohol-dependent patients: differences in psychological functioning between high- and low-frequency alcohol consumers.

Hiltunen AJ, Koechling UM, Voltaire-Carlsson A, Borg S.

Alcohol Alcohol. 1996 Jul;31(4):429-38.

PMID:
8879293
25.

Factors associated with successful withdrawal from methadone maintenance treatment in Sweden.

Eklund C, Hiltunen AJ, Melin L, Borg S.

Int J Addict. 1995 Aug;30(10):1335-53.

PMID:
7591348
26.

Neuropsychological changes during steady-state drug use, withdrawal and abstinence in primary benzodiazepine-dependent patients.

Tönne U, Hiltunen AJ, Vikander B, Engelbrektsson K, Bergman H, Bergman I, Leifman H, Borg S.

Acta Psychiatr Scand. 1995 May;91(5):299-304.

PMID:
7639085
27.

Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients.

Hiltunen AJ, Lafolie P, Martel J, Ottosson EC, Boreus LO, Beck O, Borg S, Hjemdahl P.

Psychopharmacology (Berl). 1995 Mar;118(2):122-6.

PMID:
7617797
28.
29.

Discriminative stimulus effects and receptor binding of enantiomeric pairs of cannabinoids in rats and pigeons; a comparison.

Järbe TU, Hiltunen AJ, Mathis DA, Hanŭs L, Breuer A, Mechoulam R.

J Pharmacol Exp Ther. 1993 Feb;264(2):561-9.

PMID:
8382275
30.

Acute and chronic ethanol tolerance: operant behaviour in naive and ethanol tolerant rats.

Hiltunen AJ, Järbe TU.

Psychopharmacology (Berl). 1992;107(4):511-6.

PMID:
1603893
31.

Cannabimimetic activity of novel enantiomeric, benzofuran cannabinoids.

Mechoulam R, Breuer A, Järbe TU, Hiltunen AJ, Glaser R.

J Med Chem. 1990 Mar;33(3):1037-43.

PMID:
2155318
32.

Acute tolerance to ethanol using drug discrimination and open-field procedures in rats.

Hiltunen AJ, Järbe TU.

Psychopharmacology (Berl). 1990;102(2):207-12.

PMID:
2274602
33.
34.
35.

Discriminative stimulus properties of ethanol: effects of cumulative dosing and Ro 15-4513.

Hiltunen AJ, Järbe TU.

Behav Pharmacol. 1989;1(2):133-140.

PMID:
11175396
36.

Concentrations of ethanol in rebreathed air of rats: correlation with the discriminative stimulus effects of ethanol.

Hiltunen AJ, Järbe TU, Hellström-Lindahl E, Croon LB, Jones AW.

Alcohol. 1989 Jan-Feb;6(1):39-43.

PMID:
2719817
37.

Separation of the discriminative stimulus effects of stereoisomers of delta 2- and delta 3-tetrahydrocannabinols in pigeons.

Jrbe TU, Hiltunen AJ, Mechoulam R, Srebnik M, Breuer A.

Eur J Pharmacol. 1988 Nov 8;156(3):361-6.

PMID:
2850933
38.
39.
40.

Enantiomeric cannabinoids: stereospecificity of psychotropic activity.

Mechoulam R, Feigenbaum JJ, Lander N, Segal M, Järbe TU, Hiltunen AJ, Consroe P.

Experientia. 1988 Sep 15;44(9):762-4.

PMID:
3416993
41.

Hyperactivity and instrumental learning deficits in methylazoxymethanol-treated rat offspring.

Archer T, Hiltunen AJ, Järbe TU, Kamkar MR, Luthman J, Sundström E, Teiling A.

Neurotoxicol Teratol. 1988 Jul-Aug;10(4):341-7.

PMID:
3226377
42.

Cannabinol and cannabidiol in combination: temperature, open-field activity, and vocalization.

Hiltunen AJ, Järbe TU, Wängdahl K.

Pharmacol Biochem Behav. 1988 Jul;30(3):675-8.

PMID:
3211977
43.
44.
45.

Comparison of desipramine, amitriptyline, zimeldine and alaproclate in six animal models used to investigate antidepressant drugs.

Danysz W, Plaznik A, Kostowski W, Malatynska E, Järbe TU, Hiltunen AJ, Archer T.

Pharmacol Toxicol. 1988 Jan;62(1):42-50.

PMID:
2965810
46.

Limited stimulus generalization between delta 9-THC and diazepam in pigeons and gerbils.

Järbe TU, Hiltunen AJ.

Psychopharmacology (Berl). 1988;94(3):328-31.

PMID:
2833760
47.

Lack of effects of prenatal exposure to lidocaine on development of behavior in rats.

Teiling AK, Mohammed AK, Minor BG, Järbe TU, Hiltunen AJ, Archer T.

Anesth Analg. 1987 Jun;66(6):533-41.

PMID:
3578864
48.

Cannabimimetic activity of cannabinol in rats and pigeons.

Järbe TU, Hiltunen AJ.

Neuropharmacology. 1987 Feb-Mar;26(2-3):219-28.

PMID:
3035413
49.

Cannabimimetic activity (delta 1-THC cue) of cannabidiol monomethyl ether and two stereoisomeric hexahydrocannabinols in rats and pigeons.

Järbe TU, Hiltunen AJ, Lander N, Mechoulam R.

Pharmacol Biochem Behav. 1986 Aug;25(2):393-9.

PMID:
3020594
50.

Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.

Hiltunen AJ, Järbe TU.

Eur J Pharmacol. 1986 Jun 17;125(2):301-4.

PMID:
3017729

Supplemental Content

Loading ...
Support Center